share_log

Oppenheimer Assumes ESSA Pharma at Outperform, Announces Price Target of $17

Oppenheimer Assumes ESSA Pharma at Outperform, Announces Price Target of $17

奥本海默认为ESSA Pharma的表现跑赢大盘,宣布目标股价为17美元
Benzinga ·  2023/06/26 06:48

Oppenheimer analyst Mark Breidenbach assumes ESSA Pharma (NASDAQ:EPIX) with a Outperform rating and announces Price Target of $17.

奥本海默分析师马克·布雷登巴赫认为ESSA Pharma(纳斯达克股票代码:EPIX)的评级为跑赢大盘,并宣布目标股价为17美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发